Tuskegee 2.0? –
May 6, 2019 – The device, which is surgically implanted in prisoners addicted to opioids, releases the well-known and widely used drug naltrexone. The drug is used to fight opioid and alcohol addictions by blocking the effects and cravings for such drugs in patients who have been clean for at least seven days. Naltrexone has been approved by the U.S. Food and Drug Administration only in the form of daily pills and monthly shots. The naltrexone implants were provided at no charge to the Louisiana correction’s department by California health care company, BioCorRx. She added that although it’s not FDA approved the implant device is still available for purchase and used by doctors in the U.S., although it’s not covered by insurance.